WINDTREE THERAPEUTICS INC /DE/ Deferred Revenue
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Deferred Revenue of $731.00 thousand as of 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-08-14
- 2018-06-30: Deferred Revenue, Current $731.00K.
- 2018-03-31: Deferred Revenue, Current $884.00K.
- 2017-12-31: Deferred Revenue, Current $884.00K.
- 2017-09-30: Deferred Revenue, Current $1.07M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-06-30 | $731.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $884.00K 10-Q · filed 2018-05-21 |
| 2017-12-31 | $884.00K 10-Q · filed 2018-08-14 |
| 2017-09-30 | $1.07M 10-Q · filed 2017-11-14 |
| 2015-12-31 | $0.00 10-K · filed 2016-03-29 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-12-31 | $43.00K 10-K · filed 2016-03-29 |
| 2014-09-30 | $95.00K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $105.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $85.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $139.00K 10-K · filed 2015-03-16 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |